Skip to content

JPMorgan at a Record High: What You’re Betting On at 15 Times Earnings

JPMorgan keeps posting record profits, and the stock keeps making record highs to match. The two are connected, and both cut against buying here. The business has rarely looked stronger. The valuation has rarely been higher against its own history. When you buy the shares at this level, you are making a specific bet about where bank earnings go over the next two years, and it is worth being clear about what that bet is.

Classical bank columns with an interest rate path stepping down beside them

The Earnings Are Probably Near a Peak

JPMorgan has been earning a return on tangible common equity in the low twenties, which is exceptional for a bank of its size and well above what the company itself has described as a normal through-cycle level in the high teens. A large part of the recent strength came from net interest income, the spread between what the bank earns on loans and securities and what it pays on deposits. Higher rates widened that spread, and deposit costs lagged the way up.

Now rates are being cut. I have argued that the cut itself is not the trade, and for the banks that is literally true: as easing plays out, asset yields reprice down faster than deposit costs come down, which compresses the spread. Management has said for a while that net interest income was running above a sustainable pace and would normalize lower. Credit costs are also drifting back toward normal from unusually low levels, which is another headwind to earnings even if it is a sign of a healthy book. Add those together and 2026 earnings could be flat to down against 2025, not because anything went wrong, but because the tailwinds that lifted the last two years are turning.

The Valuation Is Doing Something Unusual

For most of the past decade, large US banks traded between one and one and a half times tangible book value, and JPMorgan usually sat at the top of that range as the quality name. It has recently traded closer to two and a half to three times tangible book, and around fifteen times earnings, which is a bank multiple that looks more like a quality industrial. The JPMorgan valuation page puts the current reading against its own five-year range, and the gap is large. The market is paying that because JPMorgan has proven it can hold a premium return on equity through different environments, it took share during the regional bank stress, and it has the balance sheet to buy back stock aggressively.

All of that is fair. The problem is that you are paying a peak multiple on what may be peak earnings, and that combination has historically not been a great entry point for any stock, bank or not.

The multiple has re-rated well above its old range Approximate price to tangible book value 1.5x 0x 2021202220232024now ~2.5-3x

The Case for Owning It Anyway

Jamie Dimon will not run this bank forever, but the bench is deep and the culture of over-provisioning and stress-testing is institutional at this point. A cutting cycle that comes alongside a soft landing is not bad for a bank overall. Loan demand can pick up, capital markets and investment banking fees recover, and a steeper yield curve eventually helps net interest income again on the other side, though the longer standoff over inflation is the reason I would not assume the curve normalizes quickly. If the economy avoids a real recession, JPMorgan’s earnings dip and then resume growing, and the stock probably grinds higher with them. The premium multiple survives as long as the return on equity stays above peers.

PathRates and economyJPMorgan earningsStock outcome
Soft landingGradual cuts, no recessionDip in 2026, growth resumesGrinds higher, premium holds
Hard landingFaster cuts into a recessionCredit costs jump, earnings fallMultiple compresses, 20%+ drawdown
No landingCuts paused, rates stay highNet interest income holds up longerBest near-term case, flat multiple
The stock is a leveraged read on which of these the next 18 months looks like.
Bar chart of JPMorgan return on tangible common equity by year, running in the low twenties, above the company's stated through-cycle target
Return on equity this far above the through-cycle target usually does not last indefinitely.

The Bet, and When I’d Add

I own JPMorgan and I am holding it. Selling a compounder on valuation alone is a mistake I have made before. But I am not adding at a record high on earnings the company itself keeps calling above trend. The JPMorgan quote page has the live figures, and the quant rating tool flags the same Valuation problem this article does. My working forecast is a modest earnings dip next year and then a return to growth, which points to a stock that treads water rather than repeating the last three years. A recession scare that takes it back toward one and a half to two times tangible book is where I would add without hesitating, because the franchise was never the question. The price is.

Gavin Thorne writes on equity strategy and company-level research. This article reflects his personal research process and is intended for informational purposes only. It does not constitute investment advice.

Leave a Reply

Your email address will not be published. Required fields are marked *